Last updated on May 2017

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry


Brief description of study

Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

Detailed Study Description

We anticipate a number of observational studies will be developed from the data collected in the IPF-PRO registry. All planned analyses will be performed by the DCRI statistical team. Planning of the analyses will be done as a coordinated effort between the teams at the DCRI and Boehringer Ingelheim (refer to the organizational chart and committee descriptions in Section 10 for more details).

We anticipate multiple presentations, manuscripts, and abstracts based on data collected in the IPF-PRO registry. For each such analysis, we will require an approved Statistical Analysis Plan (SAP) prior to data analysis. At the end of the registry, a single report will be compiled summarizing all milestone analyses performed throughout the conduct of the registry.

Clinical Study Identifier: TX11943

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Keri Turner

Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation
Lexington, KY USA
  Connect »